Integrative multi-omics profiling of insomnia-related molecular features reveals microbiome, immune, and therapy-relevant heterogeneity in colorectal cancer
Open Access
- 6 October 2026
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (10)
Abstract
Emerging evidence implicates insomnia as a potential risk factor in carcinogenesis, potentially involving systemic inflammation, circadian disruption, and microbiome alterations. However, the molecular associations linking insomnia-related features to colorectal cancer (CRC), particularly with respect to tumor biology, immune microenvironmental states, and therapy-relevant phenotypes, remain largely unexplored. Multi-omics integration of genomic, transcriptomic, and microbiome data from 3,026 CRC patients across seven independent cohorts, including a large, well-annotated Clinical Omics study of Colorectal Cancer in China (COCC) cohort, enabled insomnia-based molecular classification through unsupervised non-negative matrix factorization (NMF) clustering. The insomnia subtype (IS) was biologically characterized via pathway enrichment, immune deconvolution, microbial profiling, and single-cell transcriptomics. Furthermore, an insomnia score (ISscore) was developed and validated in multiple cohorts for risk stratification and assessment of treatment-response-related indicators in CRC. Unsupervised clustering revealed two distinct molecular subtypes (IS1/IS2), with IS2 demonstrating significantly poorer survival. IS2 exhibited marked activation of EMT/angiogenesis pathways versus cell cycle activation in IS1. The IS2 microenvironment showed increased immunosuppression-related infiltration and exhausted T cell signatures, together with intratumoral microbiome variation characterized by depletion of Ruminococcaceae UCG-002 and enrichment of Hungatella/Selenomonas. The ISscore system stratified survival risk and was associated with computational indicators of immunotherapy response. Single-cell analysis nominated PPIA-BSG as a potential cell-cell communication signal involving high-ISscore tumor cells, CXCL12+ endothelial cells, and CLEC9A+ dendritic cell subsets. This multi-omics characterization of insomnia-CRC interplay suggests that insomnia-related molecular features are associated with an immunologically distinct and microbiome-altered tumor ecosystem. The ISscore provides a reproducible framework for capturing insomnia-related molecular heterogeneity, supporting risk stratification and future evaluation of therapy-relevant phenotypes. IMPORTANCE: Chronic insomnia affects millions, but it is not typically considered a cancer risk factor. Our study, analyzing vast biological data from over 3,000 colorectal cancer patients, uncovers a potential link between a person’s predisposition to insomnia and their risk of developing this disease. This suggests that the biological pathways related to sleep may play a role in cancer development. Understanding this connection opens up new avenues for identifying individuals at higher risk and developing novel prevention strategies for colorectal cancer.Keywords
Funding Information
- Noncommunicable Chronic Disease National Science and Technology Major Project (2023ZD0501600)
- National Natural Science Foundation of China-Guangdong Joint Fund (No. 82272422,No. 82573725)
- Shenzhen Medical Research Special Project (No. D2401005)
- Basic and Applied Basic Research Foundation of Guangdong Province (No. 2024A1515012269)
- Basic and Applied Basic Research Foundation of Guangdong Province (No. 2023A1515110196)
- Youth S&T Talent Support Program of Guangdong Provincial Association for Science and Technology (No. SKXRC2025127)
- Guangdong Provincial Postdoctoral Science Foundation (No. GZC20233214)
This publication has 64 references indexed in Scilit:
- STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapyBioactive Materials, 2024
- Circadian disruption in cancer hallmarks: Novel insight into the molecular mechanisms of tumorigenesis and cancer treatmentCancer Letters, 2024
- tigeR: Tumor immunotherapy gene expression data analysis R packageiMeta, 2024
- Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancerCancer Cell, 2024
- Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?Cancer Letters, 2022
- Sleep Deprivation Exacerbates Seizures and Diminishes GABAergic Tonic InhibitionAnnals of Neurology, 2021
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyCancer Cell, 2019
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- InsomniaJAMA, 2013